GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646…
A New Era of Regional Digital Entertainment Begins with a Dedicated Platform for Telugu, Tamil, Kannada, Malayalam, and More. In…
One of the largest Japan focused biotech funds to dateSAN FRANCISCO & TOKYO--(BUSINESS WIRE)--AN Venture Partners (ANV), a global biotech…
Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof of concept for potential once-weekly oral administration. Preclinical…
BENGALURU, India, June 19, 2025 /PRNewswire/ -- As part of its global Community Impact program focused on advancing digital inclusion…
June 19, 2025 01:00 ET | Source: Addex Therapeutics Strong cash position of CHF2.8 million at end of Q1 2025GABAB…
June 18, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June 18, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a…
BERLIN, June 17, 2025 /PRNewswire/ -- Tongji Day and Tongji-German Symposium 2025 was successfully held in Berlin on June 13,…
SAN FRANCISCO and LONDON, June 17, 2025 /PRNewswire/ -- Owl Ventures, the world's largest venture capital firm focused on education…
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics,…